Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening: A Clinical Study in Brazil

NCT05396781 is registered in ClinicalTrials.gov with Anandasabapathy, Sharmila, M.D. as lead sponsor.

NCT NCT05396781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05396781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening: A Clinical Study in Brazil
Lead sponsor
Anandasabapathy, Sharmila, M.D.
Phase
Phase 2
Overall status
Completed
Start date
January 13, 2022
Completion date
January 20, 2022
Enrollment
41 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prior history of squamous cell dysplasia and /or neoplasia, suspected or known squamous cell neoplasia